“…The authors discuss challenges to be tackled in the future to make AF2 even more helpful in drug discovery, such as improving predictions of different conformation states, structures with post-translational modifications, multidomain structures, and protein–ligand complexes. Different authors performed virtual screening using AF2 structures and docking, − comparing the results to the ones obtained using experimental structures or structures from homology modeling. AF2 structures showed worse enrichment of known active compounds when compared to holo structures. − This result was explained by the observation that AF2 structures usually present a significant collapse of the binding site in comparison to holo structures, being more closely related to the apo structures .…”